# Randomized Trial of Creatine-kinase Leak After Rosuvastatin At the Time of Percutaneous Coronary Intervention

Study · id `cardio:ct-nct01968577` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01968577](<https://clinicaltrials.gov/study/NCT01968577>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01968577

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 528 participants.

## Technical summary

Registry record NCT01968577. Randomized; no masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 528 participants (planned count; ClinicalTrials.gov record NCT01968577, source copy `cardio:ctgov-nct01968577-2013-10-24`, retrieved 2026-10-26)
- Start date: 2011-03 (registry gives no type) (ClinicalTrials.gov record NCT01968577, source copy `cardio:ctgov-nct01968577-2013-10-24`, retrieved 2026-10-26)
- Primary completion: 2013-12 (anticipated) (ClinicalTrials.gov record NCT01968577, source copy `cardio:ctgov-nct01968577-2013-10-24`, retrieved 2026-10-26)
- Completion: 2013-12 (anticipated) (ClinicalTrials.gov record NCT01968577, source copy `cardio:ctgov-nct01968577-2013-10-24`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT01968577, source copy `cardio:ctgov-nct01968577-2013-10-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01968577-2013-10-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Randomized Trial of Creatine-kinase Leak After Rosuvastatin At the Time of Percutaneous Coronary Intervention
- Acronym: CLEAR-PCI
- Condition: Coronary Artery Disease
- Intervention (Drug): Rosuvastatin
- Lead sponsor: Kleber Bomfim Araujo Martins
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry intervention name matches this record: Rosuvastatin (`cardio:rosuvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)

## Provenance

Content hash: 23d597f8934c094ea6a9040238ccb9e8ac2961782b2928a4b731a562c6e56bc2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
